Form 4 for ELAN Elanco Animal Health Inc
Accepted 2023-03-13 00:00:00 ET · period of report 2023-03-10 · accession 0001415889-23-004744 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-03-13 | 2023-03-10 | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | P - Purchase | $9.60 | +15.0K | 45.0K | +50% | +$144.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-10 | P | A | 15,000 | $9.60 | 45,000 | I Revocable Trust | — | — | (F1) Reflects the weighted average price of 15,000 shares of common stock of Elanco Anima Health Inc. purchased by the reporting person in multiple transactions on March 10, 2023 with purchase prices ranging from $9.585 to $9.5999 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |